Cotinga Pharmaceuticals Releases Additional Interim Data of Phase 1b/2a Combination Trial of COTI-2 in Solid Tumors Jul 18, 2019 12:40PM
Cotinga Pharmaceuticals Doses First Patient in Third Cohort of Phase 1b/2a Combination Trial of COTI-2 in Solid Tumors Jun 27, 2019 12:18PM
Cotinga Pharmaceuticals Announces Initiation of Next Cohort of Phase 1b/2a Combination Trial of COTI-2 in Solid Tumors Jun 5, 2019 12:42PM
Cotinga Pharmacueticals Announces Closing of Second Tranche of Unit Offering Jun 4, 2019 06:01PM
Cotinga Pharmacueticals Announces Closing of Unit Offering May 22, 2019 05:26PM
View Older Stories

May 8, 2019 11:10AM Cotinga Pharmaceuticals Releases Early Interim Data of Phase 1b/2a Combination Trial of COTI-2 in Solid Tumors
Apr 5, 2019 01:18PM Cotinga Pharmaceuticals Reports Fiscal 2019 Third Quarter Financial and Operating Results
Mar 19, 2019 11:00AM Cotinga Pharmacueticals Provides Scientific and Business Update at Annual General Meeting and Announces Unit Offering
Feb 26, 2019 11:08AM Cotinga Pharmaceuticals Doses First Patient in Second Cohort of Phase 1b/2a Combination Trial of COTI-2 in Solid Tumors
Jan 29, 2019 10:21AM Cotinga Pharmaceuticals Doses Cohort 1 Patients With Combination Therapy in Phase 1b/2a Trial of COTI-2
Jan 15, 2019 08:00AM Cotinga Pharmaceuticals Doses First Patient With Combination Therapy in Phase 1b/2a Trial of COTI-2
Jan 8, 2019 12:20PM Cotinga Pharmaceuticals Enrolls Two Patients for Combination Therapy in Phase 1b/2a Trial of COTI-2
Jan 3, 2019 12:32PM Cotinga Pharmaceuticals Reports Fiscal 2019 Second Quarter Financial and Operating Results
Nov 5, 2018 08:00AM Cotinga Pharmaceuticals Announces Research Partnership with St. Vincent’s University Hospital to Evaluate COTI-2
Oct 2, 2018 08:00AM Cotinga Pharmaceuticals Reports Fiscal 2019 First Quarter Financial and Operating Results
Sep 19, 2018 08:00AM Cotinga Pharmaceuticals Announces Presentation on COTI-2 at 11th International Symposium on Translational Research in Oncology
Aug 29, 2018 08:00AM Cotinga Pharmaceuticals Reports Fiscal 2018 Fourth Quarter and Full Year Financial and Operating Results
Jul 2, 2018 04:30PM Cotinga Pharmaceuticals Announces Management and Board Changes
May 24, 2018 08:00AM Cotinga Pharmaceuticals Announces FDA Clearance of Significant Protocol Changes for COTI-2 Clinical Program
May 17, 2018 07:30AM Cotinga Pharmaceuticals Announces Presentation on COTI-2 at the 2018 American Society of Clinical Oncology Annual Meeting
May 4, 2018 08:00AM Cotinga Pharmaceuticals Closes $2.0M Private Placement
Apr 3, 2018 05:00PM Cotinga Pharmaceuticals Reports Fiscal 2018 Third Quarter Financial and Operating Results
Apr 3, 2018 08:00AM Cotinga Pharmaceuticals Announces Presentation on COTI-2 at the American Association for Cancer Research (AACR) Annual Meeting 2018
Mar 20, 2018 07:00AM Cotinga Pharmaceuticals Provides Update on COTI-2 Clinical Programs
Mar 6, 2018 07:00AM Cotinga Pharmaceuticals to Present at 30th Annual ROTH Conference
Jan 25, 2018 08:00AM Cotinga Pharmaceuticals Announces Publication of Positive Data from Preclinical Study of COTI-2 in PLOS ONE
Jan 8, 2018 07:00AM Critical Outcome Technologies Changes Name to Cotinga Pharmaceuticals
Dec 29, 2017 05:00PM Critical Outcome Technologies Reports Fiscal 2018 Second Quarter Financial and Operating Results
Dec 28, 2017 07:00AM Critical Outcome Technologies Awards Stock Options
Dec 21, 2017 07:00AM Critical Outcome Technologies Provides Scientific and Business Update at Annual General Meeting and Announces Approval of Name Change
Dec 19, 2017 07:00AM Critical Outcome Technologies Announces Pharmacodynamic Data and Positive Signals of Efficacy from Phase 1 Dose Escalation Portion of COTI-2 Trial in Gynecological Malignancies
Dec 6, 2017 05:45PM Critical Outcome Technologies Annual and Special Meeting of Shareholders Rescheduled
Nov 15, 2017 07:00AM Critical Outcome Technologies Announces Pharmacokinetic Data From Phase 1 Dose Escalation Portion of COTI-2 Trial in Gynecological Malignancies
Oct 18, 2017 07:00AM Critical Outcome Technologies Closes Second Tranche of $2 Million Private Placement
Oct 11, 2017 07:00AM Critical Outcome Technologies Announces First Patient Dosed in Phase 1 Trial of COTI-2 in Head and Neck Squamous Cell Carcinoma
Sep 29, 2017 05:57PM Critical Outcome Technologies Reports Fiscal 2018 First Quarter Financial and Operating Results
Sep 20, 2017 07:00AM Critical Outcome Technologies Closes $1.5 Million Private Placement
Sep 7, 2017 08:00AM Critical Outcome Technologies Announces CEO to Co-chair Global Genes Rare Partnering & Investor Forum
Sep 5, 2017 08:00AM Critical Outcome Technologies to Present at Rodman & Renshaw 19th Annual Global Investment Conference
Aug 28, 2017 08:30AM Critical Outcome Technologies Announces Fourth Quarter and Full Year 2017 Financial Results
Aug 14, 2017 08:00AM Critical Outcome Technologies Completes Phase 1 Dose Escalation Portion of COTI-2 Trial in Gynecological Malignancies
Jun 28, 2017 09:15AM Critical Outcome Technologies Addresses Recent Trading Activity
Jun 23, 2017 08:30AM Critical Outcome Technologies Announces Share Consolidation
May 15, 2017 09:04AM Cott Corp. (COT) Announces CHEP as New U.S. Pallet Provider
May 15, 2017 09:00AM CHEP Signs New Agreement with Cott to Become Its Pallet Provider in the U.S.
May 11, 2017 08:30AM Critical Outcome Technologies Appoints Experienced Biotech Leader as Chief Scientific Officer
Mar 17, 2017 08:30AM Critical Outcome Technologies Announces CEO to Moderate Rare Diseases Panel at BIO-Europe
Mar 16, 2017 08:30AM Critical Outcome Technologies Reports Third Quarter Financial and Operating Results for Fiscal Year 2017
Feb 1, 2017 08:30AM Critical Outcome Technologies Announces Departure of Chief Scientific Officer
Jan 17, 2017 08:30AM Critical Outcome Technologies to Be a Panelist and Presenter at Cantech Investment Conference in Toronto
Jan 10, 2017 08:30AM Critical Outcome Advances to Fourth Cohort in Phase 1 Study of COTI-2 in Gynecologic Cancers
Jan 3, 2017 08:30AM Critical Outcome Technologies Awards Stock Options
Dec 19, 2016 08:50AM Critical Outcome Technologies Reports Second Quarter Financial and Operating Results for Fiscal 2017
Dec 8, 2016 08:30AM Critical Outcome Technologies Appoints Alison Silva as Chief Executive Officer
Oct 17, 2016 08:30AM Critical Outcome Technologies Awards Stock Options
View Older Stories